HomeCompareALZCF vs ARCC

ALZCF vs ARCC: Dividend Comparison 2026

ALZCF yields 1.16% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALZCF wins by $7.55M in total portfolio value· pulled ahead in Year 3
10 years
ALZCF
ALZCF
● Live price
1.16%
Share price
$182.02
Annual div
$2.11
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.57M
Annual income
$6,495,363.68
Full ALZCF calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — ALZCF vs ARCC

📍 ALZCF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALZCFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALZCF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALZCF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALZCF
Annual income on $10K today (after 15% tax)
$98.53/yr
After 10yr DRIP, annual income (after tax)
$5,521,059.13/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, ALZCF beats the other by $5,521,058.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALZCF + ARCC for your $10,000?

ALZCF: 50%ARCC: 50%
100% ARCC50/50100% ALZCF
Portfolio after 10yr
$3.80M
Annual income
$3,247,682.42/yr
Blended yield
85.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

ALZCF
No analyst data
Altman Z
4.9
Piotroski
7/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALZCF buys
0
ARCC buys
0
No recent congressional trades found for ALZCF or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALZCFARCC
Forward yield1.16%10.82%
Annual dividend / share$2.11$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%-50%
Portfolio after 10y$7.57M$24.5K
Annual income after 10y$6,495,363.68$1.16
Total dividends collected$7.46M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ALZCF vs ARCC ($10,000, DRIP)

YearALZCF PortfolioALZCF Income/yrARCC PortfolioARCC Income/yrGap
1$10,932$231.84$11,381$541.15$449.00ARCC
2$12,171$473.72$12,621$284.08$450.00ARCC
3← crossover$14,009$985.81$13,827$145.31+$182.00ALZCF
4$17,110$2,120.87$15,062$73.43+$2.0KALZCF
5$23,150$4,841.93$16,364$36.89+$6.8KALZCF
6$37,015$12,245.00$17,757$18.49+$19.3KALZCF
7$76,203$36,596.51$19,258$9.25+$56.9KALZCF
8$222,361$140,824.10$20,880$4.63+$201.5KALZCF
9$1,006,015$768,088.75$22,636$2.32+$983.4KALZCF
10$7,571,800$6,495,363.68$24,539$1.16+$7.55MALZCF

ALZCF vs ARCC: Complete Analysis 2026

ALZCFStock

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.

Full ALZCF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this ALZCF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALZCF vs SCHDALZCF vs JEPIALZCF vs OALZCF vs KOALZCF vs MAINALZCF vs HTGCALZCF vs GBDCALZCF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.